Molecular mechanisms linking amyloid β toxicity and Tau hyperphosphorylation in Alzheimer׳s disease

Free Radical Biology & Medicine
A LloretJ Viña

Abstract

Neurofibrillary tangles (aggregates of cytoskeletal Tau protein) and senile plaques (aggregates mainly formed by amyloid β peptide) are two landmark lesions in Alzheimer׳s disease. Some researchers have proposed tangles, whereas others have proposed plaques, as primary lesions. For a long time, these were thought of as independent mechanisms. However, experimental evidence suggests that both lesions are intimately related. We review here some molecular pathways linking amyloid β and Tau toxicities involving, among others, glycogen synthase kinase 3β, p38, Pin1, cyclin-dependent kinase 5, and regulator of calcineurin 1. Understanding amyloid β and Tau toxicities as part of a common pathophysiological mechanism may help to find molecular targets to prevent or even treat the disease.

References

May 1, 1995·Neurobiology of Aging·J LewJ H Wang
Jul 21, 1999·Neuroscience Research·K Y LeeR N Johnston
Mar 29, 2000·JAMA : the Journal of the American Medical Association·J NäslundJ D Buxbaum
Dec 6, 2001·Trends in Molecular Medicine·D A ButterfieldA Castegna
Mar 22, 2003·Stroke; a Journal of Cerebral Circulation·Kazuko AokiYoshihiro Wakayama
Mar 12, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Walter J BrechtYadong Huang
Oct 21, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Samantha Cicero, Karl Herrup
Mar 17, 2006·Nature·Sylvain LesnéKaren H Ashe
May 3, 2006·The FEBS Journal·Gennady ErmakKelvin J A Davies
Jun 2, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Atul DeshpandeJorge Busciglio
Feb 13, 2007·Cancer Cell·Ignacio DoladoAngel R Nebreda
Jun 21, 2007·PloS One·Simon MelovAshley I Bush
Jun 28, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kelvin J A DaviesXavier Estivill
Sep 15, 2007·The Journal of Biological Chemistry·Matthew TownsendDennis J Selkoe
Oct 3, 2007·Journal of Neurochemistry·Ian KelleherWendy Noble
Oct 4, 2007·Archives of Biochemistry and Biophysics·Amber N MitchellDana R Crawford
Jun 14, 2008·Proceedings of the National Academy of Sciences of the United States of America·Jie ZhangKarl Herrup
Aug 30, 2008·The Journal of Biological Chemistry·Charles G Glabe
Sep 25, 2009·Journal of Bioenergetics and Biomembranes·Rukhsana Sultana, D Allan Butterfield
Dec 3, 2009·Neuropharmacology·Lenka Munoz, Alaina J Ammit
May 19, 2010·Archives of Biochemistry and Biophysics·Tilman GruneKelvin J A Davies
Jun 18, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gennady ErmakKelvin J A Davies
Nov 24, 2011·PloS One·María Llorens-MartínJesús Avila
Dec 4, 2012·The Journal of Clinical Investigation·Philip T T LyWeihong Song
Feb 2, 2013·Free Radical Biology & Medicine·Gennady Ermak, Kelvin J A Davies
Apr 17, 2014·Biochimica Et Biophysica Acta·Marzia PerluigiFabio Di Domenico

❮ Previous
Next ❯

Citations

Nov 29, 2015·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Gary W Small, Susan Greenfield
Jul 30, 2015·Neurochemistry International·Yu Pong NgNancy Y Ip
May 18, 2016·Mechanisms of Ageing and Development·Gernot FruhmannVanessa Franssens
Jul 5, 2016·International Journal of Molecular Sciences·Ivana CacciatoreAntonio Di Stefano
Jul 10, 2016·Antioxidants & Redox Signaling·Vicent Bonet-CostaKelvin J A Davies
Oct 14, 2016·Journal of Medicinal Chemistry·Ulli RothweilerJohn S Mjøen Svendsen
Mar 22, 2019·Protein Science : a Publication of the Protein Society·Manuel A CastroCharles R Sanders
Jan 13, 2018·Wiley Interdisciplinary Reviews. RNA·M Laura IddaMyriam Gorospe
Dec 5, 2017·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Shelli R KeslerUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Dec 23, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Qian LiuXuebo Liu
Sep 10, 2015·Biomolecular Concepts·Myra E Conway, Christopher Lee
Jan 29, 2020·Alzheimer Disease and Associated Disorders·Ayesha Z SherzaiDean Sherzai
Jul 18, 2020·Journal of Food Biochemistry·Tao ZhouYing Gao
Jul 4, 2020·The Journal of Biological Chemistry·Rita MarinelliFrancesco Galli
Sep 16, 2016·Neural Plasticity·Francisco J CarvajalWaldo Cerpa
Feb 1, 2017·Molecular Brain·Daisuke TanokashiraWataru Araki
Jun 11, 2017·Archives of Pharmacal Research·Ji Yeon JangYeon Hee Seong
Mar 20, 2019·Expert Review of Neurotherapeutics·Rohit SharmaP K Prajapati
Apr 11, 2019·Molecular Neurobiology·Geir BjørklundSalvatore Chirumbolo
Apr 15, 2017·Journal of Alzheimer's Disease : JAD·Xiang-Zhen YuanLan Tan
Mar 14, 2019·International Journal of Molecular Sciences·Noman Bin AbidMyeong Ok Kim
Jun 13, 2020·Journal of Central Nervous System Disease·Abir Abdullah AlamroSamina Hyder Haq
May 20, 2020·Frontiers in Neuroscience·Ajay KumarXiaofeng Dai
Nov 24, 2020·Frontiers in Endocrinology·Jorge Berlanga-AcostaPedro A Valdés-Sosa
Jan 29, 2021·Nature Reviews. Molecular Cell Biology·Begoña Canovas, Angel R Nebreda
Dec 4, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Ching-Hsuan ChouChia-Ron Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.